Overview

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Status:
RECRUITING
Trial end date:
2024-10-12
Target enrollment:
Participant gender:
Summary
Evaluate the Safety and Pharmacokinetics of MBX 2109 in Adult Subjects with Normal and Impaired Renal Function
Phase:
PHASE1
Details
Lead Sponsor:
MBX Biosciences